Randomized trials to optimize treatment of multidrug-resistant tuberculosis. - Wikidata - awgldk - TriplyDB

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

http://www.wikidata.org/entity/Q33305269

about

TMC207: the first compound of a new class of potent anti-tuberculosis drugs European union standards for tuberculosis care Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait Priorities for tuberculosis research: a systematic review.Extensively drug-resistant tuberculosis: a new face to an old pathogen.Current development and future prospects in chemotherapy of tuberculosis Ethics, human rights and programmatic management of drug-resistant tuberculosis.Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.Preventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at?Extensively drug-resistant tuberculosis: new strains, new challenges.Mathematical models of the epidemiology and control of drug-resistant TB.Emerging drugs for the treatment of tuberculosis.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.Induction of mycobacterial resistance to quinolone class antimicrobials Unorthodox approach to the development of a new antituberculosis therapy.Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China.

P2860

Q24632091-538706A2-F123-4DE5-BDB3-260FD2692C8C Q26823223-08EDFF4C-9194-4433-9385-947CDC096896 Q26824812-FD47D7B5-4FA3-4165-B8C4-08E724328F21 Q28473126-17EEE233-D64D-47AA-9301-0B1BA9D150E4 Q28476110-C5A3D827-8E88-43C4-9EF9-559E859F653D Q28476125-318BC503-63C0-4A87-98C0-975E6B4BF718 Q28482730-9D5646C0-05E5-4FDE-8CD4-B108FCE8B8C1 Q28551033-59E916B1-5EAC-4E60-B297-909E021F5098 Q30840887-BA0DA7E1-CBA1-4C4C-A9FD-2DE1B63CC2BF Q33872796-08BD9C39-50D8-479C-AC19-1A1ED4C2A81D Q34351616-C780FDE3-D788-4790-B823-41EB46446787 Q34453677-8C00EB55-F3FA-401B-85B4-E7BCD77BF70D Q35705874-743AA4B0-AA8D-4F3B-8702-4605CBFFE646 Q35746496-956D94E3-B5D6-486D-A43A-5E34F8FECD30 Q36461593-343674A1-8397-4E70-86F6-3821687F08B3 Q36647864-4D8E68A0-9613-448F-85D1-DBEFDC485DD7 Q37291363-E81E461F-3602-4B6F-9CD6-94FC1EB48494 Q37754966-6A5404B8-60B7-44FF-8846-C4BEA6800661 Q37792105-59E2D969-9B71-4D77-87B6-EE4BA43964D6 Q39967041-7EF712CD-D4DD-4589-9718-4120472A9256 Q40076101-DD23E697-1814-4F43-94B9-E89FA6499891 Q40275920-2E9AAA0E-0B5D-4BBD-9FD5-44F7108B851A Q42210567-2E51F900-F31C-42A9-8C8E-A19CEA371D2F Q42693990-547B0ED4-C36E-4BAC-A927-C4EC8D25E70E Q43092099-94B74597-1E19-4E2D-AEF7-1271500DA0E5 Q48185912-BE5D5E80-CCE8-4123-B1FE-6EA08A491728

P2860

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

http://www.wikidata.org/entity/Q33305269

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@ast

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@en

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@nl

type

label

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@ast

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@en

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@nl

prefLabel

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@ast

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@en

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@nl

P1433

Q33305269-9988AACE-9750-4720-B2EE-7257C55870BC

P1476

Q33305269-4D1F4AAC-7AAE-486F-9D6E-D68DEFDC104D

P2093

Q33305269-1B843B37-AA32-449F-A0AE-7C2532C8E470

Q33305269-42A4D885-F121-43FF-8DC0-896676CC1154

Q33305269-5A06D1E2-09B6-4D5E-87C8-498CABC510F7

Q33305269-71BF4D41-AB76-4DBE-9B82-52A0BA0AFA52

Q33305269-DD1266A8-7E12-42D6-A2F7-5E37D3C019B1

P2860

Q33305269-0B94B7F5-CE64-4C99-9D80-65A2CF62EEAC

Q33305269-0D12C2FC-BF81-4CCD-829B-9960F1C3FCF5

Q33305269-0E305CF0-F034-4B76-A86C-713896AE1985

Q33305269-0F6F5AF2-5B87-4060-8501-67BF7ABF9085

Q33305269-1061C7D3-DF83-4D48-BA9D-CEF556816916

Q33305269-1A48B2AD-ADE5-4522-AE04-065926325DE1

Q33305269-1C4A49B6-7BE3-487E-A612-63746B3F6D12

Q33305269-22BEEFF4-E81C-4087-9EE3-39D2C882510F

Q33305269-2C47127C-020A-44A8-ABD5-F7EC46B325FB

Q33305269-2F18F552-C6E0-404B-9A75-FDA1662940BD

P304

Q33305269-D7EA8B40-76AC-4FB5-B796-FFBD8AB70BC5

P31

Q33305269-9BC8FC34-F424-4B26-BC38-11DF1EB8EBC9

P356

Q33305269-F76207F9-F914-4AAC-B900-34295A9EA68A

P407

Q33305269-9A154C14-7A73-4FB5-A28F-1AC958FD48A3

P433

Q33305269-51AB86AB-1520-438F-A6A0-6318D03E47AC

P478

Q33305269-5B684469-8384-4EEB-82B5-AF68B38FC76C

P577

Q33305269-A79F836B-98BC-44C6-AC0D-3827795C0A9C

P5875

Q33305269-50EAF443-DBD8-4F8F-8F35-7D16B09E28A8

P698

Q33305269-02FFB12F-4F4C-4B04-A505-479ACB7BB0FE

P921

Q33305269-80108AA0-FA9A-4706-89F6-336C9A64702D

Q33305269-D60E322E-BB4E-404E-A472-04179C248F78

P932

Q33305269-D9D05800-9ED1-426E-BF27-3B6E1A84D222

P356

JOURNAL.PMED.0040292

P1433

P1476

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

@en

P2093

Carole D Mitnick

http://www.w3.org/2001/XMLSchema#string

Kenneth G Castro

http://www.w3.org/2001/XMLSchema#string

Leonard V Sacks

http://www.w3.org/2001/XMLSchema#string

Mark Harrington

http://www.w3.org/2001/XMLSchema#string

William Burman

http://www.w3.org/2001/XMLSchema#string

P2860

XDR-TB in South Africa: no time for denial or complacency

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

Imipenem for treatment of tuberculosis in mice and humans

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

Global incidence of multidrug-resistant tuberculosis

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

Cost-effectiveness of treating multidrug-resistant tuberculosis

P304

e292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.0040292

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5859012

http://www.w3.org/2001/XMLSchema#string

P698

17988168

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

2062482

http://www.w3.org/2001/XMLSchema#string